Möchten Sie immer auf dem neuesten Stand bleiben?

Today, Biocartis announced that it has entered into a research collaboration with the Medical College of Wisconsin (MCW).

Plaintiffs alleged the anticompetitive scheme forced Tracleer purchasers to pay higher prices and delayed market entry of less-costly generic versions.

George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea GMRx2 is an innovative single pill combination of three medicines designed to deliver...

PRESS RELEASE  10/03/2025, 08:00 CET Biocartis Receives European IVDR Certification for the Idylla™ CDx MSI Test Idylla™ CDx MSI Test is the Second Fully Automated Companion Diagnostic Test Approval...

New paper in Frontiers in Medicine reveals first reliable biomarker test for early kidney transplant rejection detection in living-donor recipients

Dublin, March 05, 2026 (GLOBE NEWSWIRE) -- The "Middle East Renal Biomarkers Market Size, Share & Trends Analysis Report by Biomarker (Functional Biomarkers, Upregulated Proteins), Diagnostic...

Austin,TX,USA, March 04, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Malaria Diagnostics Market Size, Trends and Insights By Technology (Rapid...

HOUSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, will showcase its...

Austin,TX,USA, March 03, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Microplate Systems Market Size, Trends and Insights By Product Type (Microplate...

GMRx2 is an innovative single pill combination of three medicines designed to deliver the blood pressure-lowering benefits of triple combination therapy early in the treatment pathway, supported by an...